GLIMITERIS M1 : View Uses, Side Effects, Dosage, Mechanism of action...

GLIMITERIS M1

Glimepiride & Metformin Hydrochloride Prolonged Release

GLIMITERIS M1 is a combination medication containing Glimepiride and Metformin Hydrochloride Prolonged Release, designed to manage type 2 diabetes mellitus effectively. This SEO-friendly guide offers comprehensive information about GLIMITERIS M1, including its uses, dosage, side effects, price, composition, and more.

Uses:

GLIMITERIS M1 is prescribed to individuals with type 2 diabetes to help control blood sugar levels.
Glimepiride belongs to the sulfonylurea class of medications and works by stimulating the pancreas to release more insulin, thus reducing blood sugar levels.
Metformin Hydrochloride Prolonged Release is a biguanide medication that improves insulin sensitivity, decreases glucose production in the liver, and reduces the absorption of glucose in the intestines.
Dosage:

The typical dosage of GLIMITERIS M1 is one tablet taken orally once daily, preferably with meals.
Dosage adjustments may be necessary based on individual response, kidney function, and other factors as determined by a healthcare provider.
It's important to follow the prescribed dosage and not exceed the recommended intake without medical guidance.
Side Effects:
Common side effects of GLIMITERIS M1 may include:

Nausea
Diarrhea
Stomach upset
Headache
Hypoglycemia (low blood sugar) when not eating regularly or after strenuous exercise
Serious side effects such as lactic acidosis (rare but serious metabolic complication), allergic reactions, and liver problems are possible but uncommon and require immediate medical attention.

Price:
The price of GLIMITERIS M1 can vary depending on factors such as brand, dosage strength, and location. Generally, a month's supply of GLIMITERIS M1 tablets may range from $20 to $50.

Composition:
GLIMITERIS M1 combines two active ingredients:

Glimepiride: A sulfonylurea medication that stimulates insulin release from the pancreas.
Metformin Hydrochloride Prolonged Release: A biguanide medication that improves insulin sensitivity and reduces glucose production.
Inactive ingredients may include hypromellose, microcrystalline cellulose, magnesium stearate, and others.

Conclusion:
GLIMITERIS M1 (Glimepiride & Metformin Hydrochloride Prolonged Release) is a valuable combination medication for effectively managing type 2 diabetes mellitus. Its dual mechanism of action targets different aspects of glucose control, making it a beneficial treatment option for individuals with diabetes. However, proper dosage management, regular monitoring of blood sugar levels, and adherence to medical advice are essential for achieving optimal therapeutic outcomes and maintaining overall health. A team of highly skilled professionals in the pharmaceutical field established Steris Healthcare Pvt Ltd in February 2018. Sterispharma is a certified pharmaceutical company by WHO, GMP, and ISO, situated in Navi Mumbai. It is dedicated to delivering high-quality medications at competitive prices to customers across India, adhering to WHO's stringent standards. Through Steris's online pharmacy, customers can conveniently purchase medicines and receive home delivery. Our primary objective at Steris is to offer a comprehensive range of healthcare products to fulfill the diverse requirements of the healthcare industry. Steris is committed to meeting the healthcare sector's demands, whether it's specialized treatments, medications for rare diseases, or essential pharmaceuticals. The range of Steris healthcare products caters to various medical needs, including Cardiology, Asthma, Respiratory, Nasal, Diabetes, Endocrinology, Gastrology, Orthopedics, Anti-infective/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental, and Dermatology. 

For further information:  EMAIL:  info@sterispharma.com  / contact@sterispharma.com    

CALL/WHATSAPP:: 7877551268, 8209542042, 8955945010, 6377716668  

BUY NOW